The oxime pro-2-PAM provides minimal protection against the CNS effects of the nerve agents sarin, cyclosarin, and VX in guinea pigs

References

• Askew BM. 1956. Oximes and hydroxamic acids as antidotes in anticholinesterase poisoning. Brit J Pharmacol 11:417–423.
   PubMed Web of Science ®Google Scholar
• Askew BM. 1957. Oximes and atropine in sarin poisoning. Brit J Pharmacol 12:340–343.
   Web of Science ®Google Scholar
• Bodor N, Shek E, Higuchi T. 1976. 1. Synthesis and properties of 1-methyl-1,6-dihydropyridine-2-carbaldoxime, a pro-drug of N-methylpyridinium-2-carbaldoxime chloride. J Med Chem 19:102–107.
   PubMed Web of Science ®Google Scholar
• Boskovic B, Tadic V, Kusic R. 1980. Reactivating and protective effects of pro-2-PAM in mice poisoned with paraoxon. Toxicol Appl Pharmacol 55:32–36.
   PubMed Web of Science ®Google Scholar
• Claire P, Wiberg K, Granelli I, Carlsson BI, Blanchet G. 2000. Stability study of a new antidote drug combination (Atropine-HI-6-prodiazepam) for treatment of organophosphate poisoning. Euro J Pharmaceut Sci 9:259–263.
   PubMedGoogle Scholar
• Clark MG, Vasilevsky S, Myers TM. 2003. Air and shock two-way shuttlebox avoidance in C57BL/6J and 129X1/SvJ mice. Physiol Behav 78:117–123.
   PubMedGoogle Scholar
• Clement J. 1979. Efficacy of pro-PAM (N-methyl-1,6-dihydropyridine-2-carbaldoxime hydrochloride) as a prophylaxis against organophosphate poisoning. Toxicol Appl Pharmacol 47:305–311.
   PubMed Web of Science ®Google Scholar
• DeMar JC, Clarkson ED, Ratcliffe RH, Campbell AJ, Thangavelu SG, Herdman CA, Leader H, Schulz SM, Marek E, Medynets MA, Ku TC, Evans SA, Khan FA, Owens RR, Nambiar MP, Gordon RK. 2010. Pro-2-PAM therapy for central and peripheral cholinesterases. Chem Biol Interact 187:191–198.
   PubMed Web of Science ®Google Scholar
• Ecobichon DJ. 2001. Toxic effects of pesticides. In: Klaassen CD, editor. Casarett and Doull’s toxicology: the basic science of poisons. 6th ed. New York: McGraw-Hill. pp 763–810.
   Google Scholar
• Eddleston M, Dawson A, Karalliedde L, Dissanavake W, Hittarage A, Azher S, Buckley NA. 2004a. Early management after self-poisoning with an organophosphorus or carbamate pesticide – a treatment protocol for junior doctors. Crit Care 8:R391–R397
   PubMed Web of Science ®Google Scholar
• Eddleston M, Singh S, Buckley N. 2004b. Organophosphorus poisoning (acute). Clin Evid 12:1941–1953.
   PubMedGoogle Scholar
• Ellman GL, Courtney KD, Andres V, Jr, Feather-Stone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95.
   PubMed Web of Science ®Google Scholar
• FDA. 2005. Food and drug administration guidance for industry, estimating the maximum safe starting dose in initial clinical trials for therapeutics in health human volunteers, Division of Drug Information, HFD-240, Center for Drug and Research Evaluation. Available online at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm078932.pdf, accessed 27 October 2010
   Google Scholar
• Gordon RK, Campbell AJ, Nambiar MP, Owens RR, Ratcliffe RH, DeMar JC, Davis AR, Hyson LA, Khan FA, Marek E, Medynets MA, Oguntayo SA, Thangavelu SG, Leader H. 2008. Pro-2-PAM: the first therapeutic drug for reactivation of organophosphate-inhibited central (brain) and peripheral cholinesterases. Proceedings of the 26th Army Science Conference. Orlando, Florida. 1–4 December 2008. Available online at: http://www.dtic.mil/cgi-bin/GetTRDoc?Location=U2&doc=GetTRDoc.pdf&AD=ADA505755, accessed 27 October 2010
   Google Scholar
• Harris LW, McDonough JH, Stitcher DL, Lennox WJ. 1984. Protection against both lethal and behavioral effects of soman. Drug Chem Toxicol 7:605–624.
   PubMed Web of Science ®Google Scholar
• Heffron PF, Hobbiger F. 1980. Does reactivation of phosphorylated acetylcholinesterase (AChE) in the brain enhance the antidotal action of pyridinium aldoximes? Br J Pharmacol 69:313P–314P
   Google Scholar
• Hurst G, Tuorinsky S, Madsen J, Newmark J, Hill B, Boardman C, Dawson J. 2007. Medical management of chemical casualties handbook. 4th ed. Chemical Casualty Care Division, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD. Available online at: http://www.dtic.mil/cgi-bin/GetTRDoc?AD=ADA416772&Location=U2&doc=GetTRDoc.pdf, accessed 27 October 2010
   Google Scholar
• Kenley RA, Howd RA, Uyeno ET. 1982. Effects of PAM, proPAM, and DFP on behavior, thermoregulation, and brain AChE in rats. Pharmac Biochem Behav 17:1001–1008.
   PubMedGoogle Scholar
• Lallement G, Clarencon D, Brochier G, Baubichon D, Galonnier M, Blanchet G, Mestries J-C. 1997. Efficacy of atropine/pralidoxime/diazepam or atropine/HI-6/prodiazepam in primates intoxicated by soman. Pharmacol Biochem Behav 56:325–332.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Dochterman LW, Smith CD, Shih T-M. 1995. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicol 16:123–132.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Lyman ME, Van Shura KE, Myers TM, Koplovitz I, Shih T-M. 2009. Monoisonitrosoacetone can prevent or terminate status epilepticus and prevent neuropathology elicited by three nerve agents. Neurosci Abs 154:8.
   Google Scholar
• McDonough JH, McMonagle J, Copeland T, Zoeffel D, Shih T-M. 1999. Comparative evaluation of benzodiazepines for control of soman-induced seizures. Arch Toxicol 73:173–478.
   Google Scholar
• McDonough JH, Shih T-M. 1997. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathy. Neurosci Biobehav Rev 13:559–579.
   Google Scholar
• McDonough JH, Zoeffel LD, McMonagle J, Copeland TL, Smith CD, Shih T-M. 2000. Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 38:1–14.
   PubMed Web of Science ®Google Scholar
• Moore DH, Clifford CB, Crawford IT, Cole GM, Baggett JM. 1995. Review of nerve agent inhibitors and reactivators of acetylcholinesterase. In: Quinn DM, Balasubramanian AS, Doctor BP, Taylor P, editors. Enzymes of the cholinesterase family. 1st ed. New York: Plenum Press. pp 297–304.
   Google Scholar
• Myers TM, Cohn SI, Clark MG. 2005. Acquisition and performance of two-way shuttlebox avoidance: effects of aversive air intensity. Learn Motiv 36:312–321.
   Google Scholar
• National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. Washington, D.C.: The National Academies Press.
   Google Scholar
• Philippens IH, Melchers BP, De Groot DM, Wolthuis OL. 1992. Behavioral performance, brain histology, and EEG sequela after immediate combined atropine/diazepam treatment of soman-intoxicated rats. Pharmacol Biochem Behav 42:711–719.
   PubMed Web of Science ®Google Scholar
• Rump S, Faff J, Borkowska G, Ilczuk I, Rabsztyn T. 1978. Central therapeutic effects of dihydroderivative of pralidoxime (pro-2-PAM) in organophosphate intoxication. Arch Int Pharmacodyn 232:321–332.
   PubMedGoogle Scholar
• Rutland JP. 1958. The effect of some oximes in sarin poisoning. Br J Pharmacol 13:399–403.
   PubMedGoogle Scholar
• Sakurada K, Matsubara K, Shimizu K, Shiono H, Seto Y, Tsuge K, Yoshino M, Sakai I, Mukoyama H, Takatori T. 2003. Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochem Res 28:1401–1407.
   PubMed Web of Science ®Google Scholar
• Shek E, Higuchi T, Bodor N. 1976a. Improved delivery through biological membranes. 2. Distribution, excretion, and metabolism of N-methyl-1,6-dihydropyridine-2-carbaldoxime hydrochloride, a pro-drug of N-methylpyridinium-2-carbaldoxime chloride. J Med Chem 19:108–112.
   PubMed Web of Science ®Google Scholar
• Shek E, Higuchi T, Bodor N. 1976b. Improved delivery through biological membranes. 3. Delivery of N-methylpyridinium-2-carbaldoxime chloride through the blood-brain barrier in its dihydropyridine form. J Med Chem 19:113–117.
   PubMed Web of Science ®Google Scholar
• Shih T-M, Duniho SM, McDonough JH. 2003. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharm 188:69–80.
   PubMed Web of Science ®Google Scholar
• Shih T-M, Kan RK, McDonough JH. 2005. In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents. Chem Biol Interact 157–158:293–303.
   PubMed Web of Science ®Google Scholar
• Shih T-M, Guarisco JA, Koplovitz I, Kan RK, Myers TM, McDonough JH. 2010c. The oxime pro-2-PAM provides minimal protection against the CNS effects of the organophosphorus nerve agents sarin, cyclosarin, and VX in guinea pigs. Toxicol Lett 196S:S271.
   Google Scholar
• Shih T-M, Maxwell DM, Koplovitz I, Kan RK, McDonough JH. 2010a. Reactivation of acetylcholinesterase activity and its therapeutic benefits in nerve agent intoxication. In: Weissman BA, Raveh L, editors. The neurochemical consequences of organophosphate poisoning in the CNS. Kerala, India: Transworld Research Network. pp 111–133.
   Google Scholar
• Shih T-M, McDonough JH. 1997. Neurochemical mechanisms in soman-induced seizures. J Appl Toxicol 17:255–264.
   PubMed Web of Science ®Google Scholar
• Shih T-M, Rowland TC, McDonough JH. 2007. Anticonvulsants for nerve agent-induced seizures: the influence of the therapeutic dose of atropine. J Pharmacol Exp Ther 320:154–161.
   PubMed Web of Science ®Google Scholar
• Shih T-M, Skovira JW, O’Donnell JC, McDonough JH. 2009a. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose. Toxicol Mech Methods 19:386–400.
   PubMed Web of Science ®Google Scholar
• Shih T-M, Skovira JW, O’Donnell JC, McDonough JH. 2009b. Central cholinesterase reactivation by oximes improves survival and terminates seizures following nerve agent intoxication. Adv Stud Biol 1:155–196.
   Google Scholar
• Shih T-M, Skovira JW, O’Donnell, JC, McDonough JH. 2010b. Treatment with tertiary oximes prevents seizures and improves survival following sarin intoxication. J Mol Neurosci 40:63–69.
   PubMed Web of Science ®Google Scholar
• Talbot BG, Harris LW, Lennox WJ, Anderson DA, Green MD, Hackley BE, Jr. 1986. Comparison of 2-PAM and Pro-2-PAM containing treatment regimens as antagonists of nerve agent-induced lethality and incapacitation. U.S. Army Medical Research Institute of Chemical Defense technical report # USAMRICD-SP-86-012, Aberdeen Proving Ground, MD. Available online at: http://www.osti.gov/energycitations/product.biblio.jsp?osti_id=6909591, accessed 27 October 2010.
   Google Scholar
• Taylor P. 2001. Anticholinesterase agents. In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill. pp 175–191.
   Google Scholar
• Vallejo-Freire AA. 1951. A simple technique for repeated collection of blood samples from guinea pigs. Science 114:524–525.
   PubMed Web of Science ®Google Scholar
• Worek F, Thiermann H, Szinicz L, Eyer P. 2004. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol 68:2237–2248.
   PubMed Web of Science ®Google Scholar